Diamond Chemical Co. v. Akzo Nobel Chemicals B.V.

517 F. Supp. 2d 212, 2007 U.S. Dist. LEXIS 35126, 2007 WL 1427014
CourtDistrict Court, District of Columbia
DecidedMay 14, 2007
DocketCivil Action 01-2118 (CKK), 02-1018(CKK)
StatusPublished
Cited by9 cases

This text of 517 F. Supp. 2d 212 (Diamond Chemical Co. v. Akzo Nobel Chemicals B.V.) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Diamond Chemical Co. v. Akzo Nobel Chemicals B.V., 517 F. Supp. 2d 212, 2007 U.S. Dist. LEXIS 35126, 2007 WL 1427014 (D.D.C. 2007).

Opinion

MEMORANDUM OPINION

COLLEEN KOLLAR-KOTELLY, District Judge.

Currently pending before the Court are cross motions brought in each of the above-captioned matters by Class Plaintiff, Diamond Chemical Company, Inc. (“Class Plaintiff’), and Defendants 1 regarding the disposition of undistributed funds derived from the settlement of these actions. Class Plaintiff seeks an order authorizing the distribution of settlement proceeds to a final group of class claimants (the “Supplemental Claimants”) and the payment of certain unpaid fees and expenses to the Claims Administrator, Heffleer, Radetich & Saitta L.L.P. (the “Claims Administrator”) and further authorizing a cy pres distribution of the settlement funds remaining thereafter (the “Remaining Settlement Fund”) to a newly created endowment fund at The George Washington University Law School (the “Endowment *214 Fund”). Defendants oppose Class Plaintiffs motion insofar as it seeks cy pres distribution of the entire Remaining Settlement Fund, and have cross-moved for an order authorizing a refund to Defendants of half of the Remaining Settlement Fund, as well as a cy pres distribution of the other half of the Remaining Settlement Fund.

Upon searching consideration of Class Plaintiffs Motion to Distribute, Defendants’ Opposition and Cross-Motion for Partial Refund, Class Plaintiffs Opposition to Defendants’ Cross-Motion, Defendants’ Reply in support of their Cross-Motion, the relevant case law, and the entire record herein, the Court concludes that the equities at issue favor a cy pres distribution of the entire Remaining Settlement Fund, and shall therefore deny Defendants’ Cross-Motion for Partial Refund. The Court shall grant-in-part Class Plaintiffs Motion to Distribute, to the extent that it seeks authorization to distribute settlement funds to the Supplemental Claimants and to pay the Claims Administrator’s additional fees and expenses. However, the Court shall hold in abeyance that portion of Class Plaintiffs Motion to Distribute that seeks an order authorizing a cy pres distribution to the Endowment Fund, and shall order Class Plaintiff to submit additional briefing as to the appropriateness of its proposed cy pres recipient.

I. BACKGROUND

The complaints in these actions were brought on behalf of a class of direct purchasers of sodium monochloroacetate and monochloroacetic acid (“MCAA”), alleging that Defendants conspired to fix, raise, maintain, or stabilize the prices and allocate markets for the sale of MCAA in the United States and elsewhere, in violation of Section 1 of the Sherman Antitrust Act, 15 U.S.C. § 1. See Cl. Pl.’s Mem. of Law in Support of Mot. to Distribute (hereinafter “Cl. PL’s Mem.”) at 6-7. The Court previously approved three settlement agreements in these actions, reached by Class Plaintiff with each of three separate defendant groups. 2 Together, these settlements yielded approximately $12.9 million for distribution to eligible class members (exclusive of deductions for attorneys fees and other expense), which were was combined into a single fund because of Defendants’ joint and several liability (the “Settlement Fund”). See CL PL’s Mem. at 2, n. 1; Defs’ Joint Mem. of P & A in Opp’n to CL PL’s Mot. (hereinafter “Defs’ Opp’n Mem.”) at 2-3.

After entering into the settlement agreements, Defendants provided Class Plaintiff with the identities and last-known addresses for all purchasers eligible to recover from the Settlement Fund. Subsequently, the Claims Administrator, who was retained by Class Counsel, mailed claim forms to class members on February 9, 2004, and again on July 9, 2004. CL PL’s Mem. at 2. On February 21, 2005, the Court approved Class Plaintiffs unopposed motion for partial distribution of the Settlement Fund, which requested that certain approved claimants receive trebled damages based on an estimated over *215 charge of 15 percent. Id. The Claims Administrator then distributed approximately $3,034,484.88 of the $12.9 million Settlement Fund. Cl. PL’s Mem. at 2 (citing Order, Akzo (D.D.C. Feb. 22, 2005), Dkt # 58; Order, Atofina, (D.D.C. Feb. 22, 2005), Dkt # 97). On April 12, 2006, the Court approved Class Plaintiffs unopposed motion to distribute proceeds from the Settlement Fund to a group of final claimants, who had not previously been mailed the class notice, and awarded portions of the Settlement Fund to pay the fees and expenses of the Claims Administrator and Class Counsel. Cl. PL’s Mem. at 3 (citing Order, Akzo (D.D.C. Apr. 12, 2006), Dkt # 62; Order, Atofina (D.D.C. Apr. 12, 2006), Dkt # 101).

According to Class Plaintiff, there is currently $6,720,407.93 remaining in the Settlement Fund. Cl. PL’s Mem. at 3; Defs’ Opp’n Mem. at 2. On February 12, 2007, Class Plaintiff moved to distribute $1,650,000 of these proceeds to a total of four Supplemental Claimants, discussed in greater detail below. CL PL’s Mem. at 3-5. In addition, Class Plaintiffs motion requests approval to distribute $4,448.87 from the Settlement Fund to the Claims Administrator for fees and expenses incurred in connection with the final administration and audit of claims. Id. at 5. According to Class Plaintiff, after these distributions, the Remaining Settlement Fund will total approximately $5,113,285.10. Id. at 6. As the settlement agreements are silent as to the disposition of any excess funds, Class Plaintiff recommends that the Court make a cy pres distribution of the Remaining Settlement Funds to a newly created endowment fund at The George Washington University Law School. Id. at 6-8. Class Plaintiff asserts that the Endowment Fund will “provide financial support for the academic and clinical programs at The George Washington University Law School that are designed to ensure the effective private enforcement of antitrust and competition laws within the United States and around the world.” Id. at 7.

On February 26, 2007, Defendants filed a partial Opposition to Class Plaintiffs motion to distribute, as well as a Cross-Motion for Partial Refund. Defendants do not object to Class Plaintiffs proposed distributions to the Supplemental Claimants or the Claims Administrator. Defs’ Opp’n Mem. at 2. Defendants do, however, oppose Class Plaintiffs motion insofar as it recommends a cy pres distribution of the entire Remaining Settlement Fund. Id. Asserting that they have a compelling equitable claim to the Remaining Settlement Fund and that the policies of the Sherman Act have been served by the distributions to the class claimants, Defendants cross-move the Court for a refund of one-half of the Remaining Settlement Fund, and a distribution of the other half of the Remaining Settlement Fund to a cy pres recipient. See generally Defs’ Opp’n Mem. In their Opposition Memorandum, Defendants “take no position on Class Plaintiffs proposed cy pres recipient,” id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Domestic Airline Travel Antitrust Litigation
378 F. Supp. 3d 10 (D.C. Circuit, 2019)
Keepseagle v. Vilsack
102 F. Supp. 3d 306 (District of Columbia, 2015)
Keeps Eagle v. Veneman
District of Columbia, 2014
Schultz v. Hungry MacHine, Inc.
298 F.R.D. 1 (District of Columbia, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
517 F. Supp. 2d 212, 2007 U.S. Dist. LEXIS 35126, 2007 WL 1427014, Counsel Stack Legal Research, https://law.counselstack.com/opinion/diamond-chemical-co-v-akzo-nobel-chemicals-bv-dcd-2007.